Prognosis of patients with new prostatitis/pelvic pain syndrome episodes

The Journal of Urology
Judith A TurnerRichard E Berger

Abstract

Little is known about the natural history of nonbacterial prostatitis/male pelvic pain syndrome, the transition from acute to chronic pelvic pain and risk factors for chronicity. In this study we determined the course of symptoms after physician visits for new nonbacterial prostatitis/pelvic pain syndrome episodes, and determined predictors of symptom persistence 1 year later. A total of 286 male health maintenance organization enrollees (87% white, mean age 46.7 years, 83% completed the 12-month followup) with recent physician visits for new prostatitis/pelvic pain episodes completed baseline, and 3, 6 and 12-month followup telephone interviews, including the National Institutes of Health Chronic Prostatitis Symptom Index in a prospective longitudinal inception cohort study. On average symptoms improved substantially during months 1 to 3, modestly from months 3 to 6 and then remained unchanged. At each followup outcomes were better for men whose initial visit was for a first lifetime episode compared with a recurrent prostatitis/pelvic pain episode. Patients with more severe symptoms (Wald chi-square 11.27, p = 0.0008) and whose episode was recurrent (OR 2.2, 95% CI 1.16 to 4.06) at baseline were significantly more likely to r...Continue Reading

References

Aug 1, 1992·Pain·Michael Von KorffSamuel F Dworkin
Dec 15, 1996·Spine·M Von Korff, K Saunders
Mar 21, 1998·The Journal of Urology·M M CollinsM J Barry
Sep 9, 2000·Annals of Internal Medicine·M McNaughton CollinsT J Wilt
Oct 27, 2001·Journal of General Internal Medicine·M McNaughton CollinsUNKNOWN Chronic Prostatitis Collaborative Research Network
Mar 26, 2002·The Journal of Urology·Judith A TurnerRichard Berger
May 29, 2002·Urology·Kathleen J PropertUNKNOWN Chronic Prostatitis Collaborative Research Network
Nov 2, 2002·BJU International·J C NickelJ M Clark
Jan 11, 2003·Urology·John N KriegerDonald E Riley
Aug 9, 2003·BMJ : British Medical Journal·Liset H M PengelKathryn M Refshauge

❮ Previous
Next ❯

Citations

Jun 28, 2005·Current Urology Reports·Vi N HuaAnthony J Schaeffer
Sep 2, 2005·Clinical Evidence·Anthony Schaeffer, Thomas Jang
Apr 5, 2011·The American Journal of Geriatric Pharmacotherapy·Daryl S Schiller, Ashish Parikh
Nov 9, 2010·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·D DelavierreJ-J Labat
Jan 1, 2008·International Journal of Antimicrobial Agents·John N KriegerDonald E Riley
Oct 5, 2006·The Journal of Pain : Official Journal of the American Pain Society·Dean A TrippUNKNOWN National Institutes of Health-Chronic Prostatitis Collaborative Research Network (NIH-CPCRN) Study Group
Nov 23, 2005·International Journal of Andrology·Ja Hyeon KuJae-Seung Paick
May 3, 2006·International Braz J Urol : Official Journal of the Brazilian Society of Urology·Amir M ZiaeeMojgan Karbakhsh
Jul 14, 2010·The Journal of Urology·J Quentin Clemens
Sep 25, 2010·Physical Therapy·Linda S Van AlstyneEsther M Haskvitz
Mar 22, 2016·Microbiology Spectrum·John N Krieger, Praveen Thumbikat

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.